On-chip micro-flow polystyrene bead-based immunoassay for quantitative detection of tacrolimus (FK506)

被引:64
作者
Murakami, Y
Endo, T
Yamamura, S
Nagatani, N
Takamura, Y
Tamiya, E
机构
[1] Japan Adv Inst Sci & Technol, Sch Mat Sci, Dept Chem Mat Sci, Tatsunokuchi, Ishikawa 9231292, Japan
[2] Fujisawa Pharmaceut Co Ltd, Biopharmaceut & Pharmacokinet Res Labs, Yodogawa Ku, Osaka 5328514, Japan
[3] Japan Sci & Technol Agcy, Tatsunokuchi, Ishikawa 9231292, Japan
基金
日本科学技术振兴机构;
关键词
tacrolimus (FK506); microfluidics; therapeutic drug monitoring; blood concentration; competitive immunoassay;
D O I
10.1016/j.ab.2004.07.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Tacrolimus (FK506) is a widely used immunosuppressant for preventing allograft rejection and the treatment of atopic dermatitis. FK506 necessitates therapeutic drug monitoring because of inter- and intrapatient variability and the lack of correlation between the administered close and the blood concentration. Previous immunoassay-based methods required a relatively long assay time and troublesome liquid-handling procedures. In the present study, we aimed to establish a rapid monitoring method for FK506 determination by using a poly(dimethylsiloxane) (PDMS)-based microfluidic device. Polystyrene beads were coated with mouse anti-FK506 antibody and placed in the flow channel. As a competitive assay, sample Solution was allowed to react in the flow channel. After the addition of the fluorogenic substrate, the fluorescent signal was observed under a microscope. As a result, the developed assay allowed a short detection time of approximately 15 min per each sample and a high sensitivity even by using only a single bead. The feasibility of performing a competitive assay using a PDMS-based antibody chip gives promising results over the existing immunoassay-based methods. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 19 条
[1]   An HPLC/MS/MS assay for tacrolimus in patient blood samples - Correlation with results of an ELISA assay [J].
Alak, AM ;
Moy, S ;
Cook, M ;
Lizak, P ;
Niggebiugge, A ;
Menard, S ;
Chilton, A .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 16 (01) :7-13
[2]  
Cogill JL, 1998, CLIN CHEM, V44, P1942
[3]   Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus [J].
Dietemann, J ;
Berthoux, P ;
Gay-Montchamp, JP ;
Batie, M ;
Berthoux, F .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (11) :2246-2249
[4]  
FIRDAOUS I, 1995, CLIN CHEM, V41, P1292
[5]  
FUNG J, 1991, TRANSPLANT P, V23, P2977
[6]  
Gewirtz Andrew T, 2002, Curr Opin Investig Drugs, V3, P1307
[7]   SIMPLIFIED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY ASSAY FOR MEASUREMENT OF TACROLIMUS AND ITS METABOLITES AND CROSS-VALIDATION WITH MICROPARTICLE ENZYME-IMMUNOASSAY [J].
GONSCHIOR, AK ;
CHRISTIANS, U ;
WINKLER, M ;
SCHIEBEL, HM ;
LINCK, A ;
SEWING, KF .
THERAPEUTIC DRUG MONITORING, 1995, 17 (05) :504-510
[8]  
GRENIER FC, 1991, TRANSPLANT P, V23, P2748
[9]   ANALYSIS OF TACROLIMUS (FK-506) IN RELATION TO THERAPEUTIC DRUG-MONITORING [J].
JUSKO, WJ .
THERAPEUTIC DRUG MONITORING, 1995, 17 (06) :596-601
[10]  
KLINTMALM GB, 1994, CLIN TRANSPLANT, V8, P207